TOM5 regulates the mitochondrial membrane potential of alveolar epithelial cells in organizing pneumonia

References

• Yilmaz S, Akinci Ozyurek B, Erdogan Y, et al. Retrospective evaluation of patients with organizing pneumonia: is cryptogenic organizing pneumonia different from secondary organizing pneumonia? Tuberk Toraks. 2017;65(1):1–8.
   PubMedGoogle Scholar
• Wang Z, Wu C, Zhu R, et al. Airway invasive aspergillosis with organizing pneumonia: a case report and review of literature. Ann Transl Med. 2020;8(7):504), doi:10.21037/atm.2020.03.162
   PubMed Web of Science ®Google Scholar
• Mueller-Mang C, Grosse C, Schmid K, et al. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics. 2007;27(3):595–615. doi:10.1148/rg.273065130
   PubMed Web of Science ®Google Scholar
• Kim SJ, Lee KS, Ryu YH, et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. AJR Am J Roentgenol. 2003;180(5):1251–1254. doi:10.2214/ajr.180.5.1801251
   PubMed Web of Science ®Google Scholar
• Kligerman SJ, Franks TJ, Galvin JR. From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. Radiographics. 2013;33(7):1951–1975. doi:10.1148/rg.337130057
   PubMed Web of Science ®Google Scholar
• Kastelik JA, Greenstone M, McGivern DV, et al. Cryptogenic organising pneumonia. Eur Respir J. 2006;28(6):1291), doi:10.1183/09031936.00100106
   PubMed Web of Science ®Google Scholar
• Araiso Y, Tsutsumi A, Qiu J, et al. Structure of the mitochondrial import gate reveals distinct preprotein paths. Nature. 2019;575(7782):395–401. doi:10.1038/s41586-019-1680-7
   PubMed Web of Science ®Google Scholar
• Vogel P, Read RW, Rehg JE, et al. Cryptogenic organizing pneumonia in Tomm5(-/-) mice. Vet Pathol. 2013;50(1):65–75. doi:10.1177/0300985812450723
   PubMed Web of Science ®Google Scholar
• Pasquali F, Agrimonti C, Pagano L, et al. Nucleo-mitochondrial interaction of yeast in response to cadmium sulfide quantum dot exposure. J Hazard Mater. 2017;324(Pt B):744–752.
   PubMedGoogle Scholar
• Kang Y, Fielden LF, Stojanovski D. Mitochondrial protein transport in health and disease. Semin Cell Dev Biol. 2018;76:142–153. doi:10.1016/j.semcdb.2017.07.028
   PubMed Web of Science ®Google Scholar
• Habich M, Salscheider SL, Riemer J. Cysteine residues in mitochondrial intermembrane space proteins: more than just import. Br J Pharmacol. 2019;176(4):514–531. doi:10.1111/bph.14480
   PubMed Web of Science ®Google Scholar
• Budzinska M, Galganska H, Karachitos A, et al. The TOM complex is involved in the release of superoxide anion from mitochondria. J Bioenerg Biomembr. 2009;41(4):361–367. doi:10.1007/s10863-009-9231-9
   PubMed Web of Science ®Google Scholar
• Kanoh S, Kobayashi H, Motoyoshi K. Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung diseases. Chest. 2005;128(4):2387–2392. doi:10.1378/chest.128.4.2387
   PubMed Web of Science ®Google Scholar
• Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–748. doi:10.1164/rccm.201308-1483ST
   PubMed Web of Science ®Google Scholar
• Williamson JD, Sadofsky LR, Hart SP. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp Lung Res. 2015;41(2):57–73. doi:10.3109/01902148.2014.979516
   PubMed Web of Science ®Google Scholar
• Huh JW, Kim DS, Oh YM, et al. Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis? Chest. 2008;133(5):1101–1106. doi:10.1378/chest.07-2116
   PubMed Web of Science ®Google Scholar
• Li S, Liu YZ, Huang H, et al. The role of histone deacetylases in the pathogenesis of idiopathic pulmonary fibrosis and cryptogenic organizing pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2019;42(5):361–366.
   PubMedGoogle Scholar
• Pujols L, Xaubet A, Ramirez J, et al. Expression of glucocorticoid receptors and in steroid sensitive and steroid insensitive interstitial lung diseases. Thorax. 2004;59(8):687–693. doi:10.1136/thx.2003.013268
   PubMed Web of Science ®Google Scholar
• Oliveira CC, Fabro AT, Ribeiro SM, et al. Evaluation of the use of transbronchial biopsy in patients with clinical suspicion of interstitial lung disease. J Bras Pneumol. 2011;37(2):168–175. doi:10.1590/S1806-37132011000200006
   PubMed Web of Science ®Google Scholar
• Strieter RM. Mechanisms of pulmonary fibrosis: conference summary. Chest. 2001;120(1 Suppl):77S–85S.
   PubMed Web of Science ®Google Scholar
• Ganzleben I, He GW, Gunther C, et al. PGAM5 is a key driver of mitochondrial dysfunction in experimental lung fibrosis. Cell Mol Life Sci. 2019;76(23):4783–4794. doi:10.1007/s00018-019-03133-1
   PubMed Web of Science ®Google Scholar
• Foster KA, Oster CG, Mayer MM, et al. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res. 1998;243(2):359–366. doi:10.1006/excr.1998.4172
   PubMed Web of Science ®Google Scholar
• Lieber M, Smith B, Szakal A, et al. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976;17(1):62–70. doi:10.1002/ijc.2910170110
   PubMed Web of Science ®Google Scholar
• Kuwano K, Hagimoto N, Nakanishi Y. The role of apoptosis in pulmonary fibrosis. Histol Histopathol. 2004;19(3):867–881.
   PubMed Web of Science ®Google Scholar
• Chung WY, Sun JS, Park JH, et al. Epithelial apoptosis as a clinical marker in idiopathic interstitial pneumonia. Respir Med. 2010;104(11):1722–1728. doi:10.1016/j.rmed.2010.05.013
   PubMed Web of Science ®Google Scholar
• Gump JM, Thorburn A. Autophagy and apoptosis: what is the connection? Trends Cell Biol. 2011;21(7):387–392. doi:10.1016/j.tcb.2011.03.007
   PubMed Web of Science ®Google Scholar
• Boya P, Gonzalez-Polo RA, Casares N, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005;25(3):1025–1040. doi:10.1128/MCB.25.3.1025-1040.2005
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Takahashi S, Yoshimi T, et al. Increases in the mRNA levels of γ-Glutamyltransferase and heme oxygenase-1 in the rat lung after ozone exposure. Biochem Pharmacol. 1997;53(7):1061–1064. doi:10.1016/S0006-2952(97)00104-4
   PubMed Web of Science ®Google Scholar
• Karam H, Hurbain-Kosmath I, Housset B. Antioxidant activity in alveolar epithelial type 2 cells of rats during the development of bleomycin injury. Cell Biol Toxicol. 1998;14(1):13–22. doi:10.1023/A:1007460320109
   PubMed Web of Science ®Google Scholar
• Dasdemir Ilkhan G, Demirci Ucsular F, Celikhisar H, et al. Original article: clinical research. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(2):e2021020.
   PubMedGoogle Scholar
• Liu H, Li Y, Zou Y, et al. Influence of miRNA-30a-5p on pulmonary fibrosis in mice with streptococcus pneumoniae infection through regulation of autophagy by beclin-1. Biomed Res Int. 2021;2021: 9963700.
   PubMed Web of Science ®Google Scholar
• Yamashita M, Saito R, Yasuhira S, et al. Distinct profiles of CD163-positive macrophages in idiopathic interstitial pneumonias. J Immunol Res. 2018;2018: 1436236.
   PubMed Web of Science ®Google Scholar
• Thomas AQ, Lane K, Phillips, 3rd J, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med. 2002;165(9):1322–1328.
   PubMed Web of Science ®Google Scholar
• Samarelli AV, Tonelli R, Marchioni A, et al. Fibrotic idiopathic interstitial lung disease: the molecular and cellular Key players. Int J Mol Sci. 2021;22(16):8952.
   PubMed Web of Science ®Google Scholar
• Wells AU, Flaherty KR, Brown KK, et al. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med. 2020;8(5):453–460. doi:10.1016/S2213-2600(20)30036-9
   PubMed Web of Science ®Google Scholar
• Maher TM, Corte TJ, Fischer A, et al. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2020;8(2):147–157. doi:10.1016/S2213-2600(19)30341-8
   PubMed Web of Science ®Google Scholar
• Vasarmidi E, Sarantoulaki S, Trachalaki A, et al. Investigation of key autophagy-and mitophagy-related proteins and gene expression in BALF cells from patients with IPF and RA-ILD. Mol Med Rep. 2018;18(4):3891–3897.
   PubMed Web of Science ®Google Scholar
• Massaro GD, Gail DB, Massaro D. Lung oxygen consumption and mitochondria of alveolar epithelial and endothelial cells. J Appl Physiol. 1975;38(4):588–592. doi:10.1152/jappl.1975.38.4.588
   PubMed Web of Science ®Google Scholar
• Madala SK, Schmidt S, Davidson C, et al. MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. Am J Respir Cell Mol Biol. 2012;46(3):380–388. doi:10.1165/rcmb.2011-0237OC
   PubMed Web of Science ®Google Scholar
• Zeng M, Huang C, Zheng H, et al. Effects of ghrelin on iNOS-derived NO promoted LPS-induced pulmonary alveolar epithelial A549 cells apoptosis. Cell Physiol Biochem. 2018;49(5):1840–1855. doi:10.1159/000493630
   PubMedGoogle Scholar
• Park WH. MAPK inhibitors, particularly the JNK inhibitor, increase cell death effects in H2O2-treated lung cancer cells via increased superoxide anion and glutathione depletion. Oncol Rep. 2018;39(2):860–870.
   PubMed Web of Science ®Google Scholar
• Mimae T, Hagiyama M, Inoue T, et al. Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema. Thorax. 2014;69(3):223–231. doi:10.1136/thoraxjnl-2013-203867
   PubMed Web of Science ®Google Scholar
• Kuwano K, Hagimoto N, Maeyama T, et al. Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab Invest. 2002;82(12):1695–1706. doi:10.1097/01.LAB.0000045084.81853.76
   PubMed Web of Science ®Google Scholar
• Mitra K, Wunder C, Roysam B, et al. A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proc Natl Acad Sci U S A. 2009;106(29):11960–5. doi:10.1073/pnas.0904875106
   PubMed Web of Science ®Google Scholar